123 related articles for article (PubMed ID: 38000983)
21. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.
Everhart J; Wright D
JAMA; 1995 May 24-31; 273(20):1605-9. PubMed ID: 7745774
[TBL] [Abstract][Full Text] [Related]
22. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
[TBL] [Abstract][Full Text] [Related]
23. BMI and HbA1c are metabolic markers for pancreatic cancer: Matched case-control study using a UK primary care database.
Lemanska A; Price CA; Jeffreys N; Byford R; Dambha-Miller H; Fan X; Hinton W; Otter S; Rice R; Stunt A; Whyte MB; Faithfull S; de Lusignan S
PLoS One; 2022; 17(10):e0275369. PubMed ID: 36197912
[TBL] [Abstract][Full Text] [Related]
24. Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study.
Gokhale M; Buse JB; Gray CL; Pate V; Marquis MA; Stürmer T
Diabetes Obes Metab; 2014 Dec; 16(12):1247-56. PubMed ID: 25109825
[TBL] [Abstract][Full Text] [Related]
25. Diabetes and the risk of pancreatic cancer.
Gullo L; Pezzilli R; Morselli-Labate AM;
N Engl J Med; 1994 Jul; 331(2):81-4. PubMed ID: 8208269
[TBL] [Abstract][Full Text] [Related]
26. Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women.
Arthur R; Kabat GC; Kim MY; Ho GYF; Chlebowski RT; Pan K; Rohan TE
Ann Epidemiol; 2019 Jan; 29():23-29.e1. PubMed ID: 30449532
[TBL] [Abstract][Full Text] [Related]
27. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.
Wang F; Gupta S; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1458-63. PubMed ID: 16896032
[TBL] [Abstract][Full Text] [Related]
28. Diabetes mellitus and risk of pancreatic cancer in China: A meta-analysis based on 26 case-control studies.
Zhang JJ; Jia JP; Shao Q; Wang YK
Prim Care Diabetes; 2019 Jun; 13(3):276-282. PubMed ID: 30553699
[TBL] [Abstract][Full Text] [Related]
29. Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan.
Tseng CM; Liao WC; Chang CY; Lee CT; Tseng CH; Hsu YC; Lin JT
Pancreatology; 2017; 17(1):76-82. PubMed ID: 27743712
[TBL] [Abstract][Full Text] [Related]
30. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies.
Huxley R; Ansary-Moghaddam A; Berrington de González A; Barzi F; Woodward M
Br J Cancer; 2005 Jun; 92(11):2076-83. PubMed ID: 15886696
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Chiu CC; Huang CC; Chen YC; Chen TJ; Liang Y; Lin SJ; Chen JW; Leu HB; Chan WL
Intern Med; 2013; 52(9):939-46. PubMed ID: 23648711
[TBL] [Abstract][Full Text] [Related]
32. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer.
Silverman DT; Schiffman M; Everhart J; Goldstein A; Lillemoe KD; Swanson GM; Schwartz AG; Brown LM; Greenberg RS; Schoenberg JB; Pottern LM; Hoover RN; Fraumeni JF
Br J Cancer; 1999 Aug; 80(11):1830-7. PubMed ID: 10468306
[TBL] [Abstract][Full Text] [Related]
33. Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan.
Chen HF; Chen P; Li CY
Diabetes Care; 2011 May; 34(5):1177-9. PubMed ID: 21398527
[TBL] [Abstract][Full Text] [Related]
34. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.
Egawa N; Lin Y; Tabata T; Kuruma S; Hara S; Kubota K; Kamisawa T
World J Gastroenterol; 2013 Apr; 19(16):2537-42. PubMed ID: 23674856
[TBL] [Abstract][Full Text] [Related]
35. Association between alcohol consumption and pancreatic cancer risk differs by glycaemic status: A nationwide cohort study.
Park JH; Han K; Hong JY; Park YS; Park JO
Eur J Cancer; 2022 Mar; 163():119-127. PubMed ID: 35065369
[TBL] [Abstract][Full Text] [Related]
36. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
[TBL] [Abstract][Full Text] [Related]
37. Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark.
Kirkegård J; Cronin-Fenton D; Heide-Jørgensen U; Mortensen FV
Gastroenterology; 2018 May; 154(6):1729-1736. PubMed ID: 29432727
[TBL] [Abstract][Full Text] [Related]
38. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
[TBL] [Abstract][Full Text] [Related]
39. A case-control study of diabetes mellitus and cancer risk.
La Vecchia C; Negri E; Franceschi S; D'Avanzo B; Boyle P
Br J Cancer; 1994 Nov; 70(5):950-3. PubMed ID: 7947103
[TBL] [Abstract][Full Text] [Related]
40. Lifestyle, body mass index, diabetes, and the risk of pancreatic cancer in a nationwide population-based cohort study with 7.4 million Korean subjects.
Park BK; Seo JH; Chung JB; Choi JK
Br J Cancer; 2022 Aug; 127(3):549-557. PubMed ID: 35444288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
